Literature DB >> 745211

Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.

J Pearn.   

Abstract

A total population study of chronic childhood spinal muscular atrophy (arrested Werdnig-Hoffmann disease, Kugelberg-Welander disease, SMA type II and III) was undertaken in north-east England to establish gene and carrier frequencies, incidence, and prevalence. The incidence of this disease was 1 in 24 100 live births. Prevalence was 1.20 per 100,000 of the general population. A technique for estimating an autosomal recessive gene frequency in the known presence of dominant new mutations (or phenocopies), using data from a segregation analysis, is described. Gene frequency was in the range (0.00451 to 0.00659 (95% confidence limits), with a working estimate of 0.0055. Carrier rates for the autosomal recessive gene concerned were 1 in 76 to 1 in 111 (95%) confidence limits), with a working estimate of 1 in 90 for genetic counselling purposes.

Entities:  

Mesh:

Year:  1978        PMID: 745211      PMCID: PMC1013753          DOI: 10.1136/jmg.15.6.409

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  11 in total

1.  Sporadic non-endemic goitrous cretinism; hereditary transmission.

Authors:  J H HUTCHISON; E M MCGIRR
Journal:  Lancet       Date:  1956-06-30       Impact factor: 79.321

2.  Chronic generalized spinal muscular atrophy of infancy and childhood. Arrested Werdnig-Hoffman disease.

Authors:  J H Pearn; J Wilson
Journal:  Arch Dis Child       Date:  1973-10       Impact factor: 3.791

3.  The genetic identity of acute infantile spinal muscular atrophy.

Authors:  J H Pearn; C O Carter; J Wilson
Journal:  Brain       Date:  1973-09       Impact factor: 13.501

4.  The gene frequency of acute Werdnig-Hoffmann disease (SMA type 1). A total population survey in North-East England.

Authors:  J H Pearn
Journal:  J Med Genet       Date:  1973-09       Impact factor: 6.318

5.  Genetics of childhood spinal muscular atrophy.

Authors:  E J Winsor; E G Murphy; M W Thompson; T E Reed
Journal:  J Med Genet       Date:  1971-06       Impact factor: 6.318

6.  Monogenic disorders.

Authors:  C O Carter
Journal:  J Med Genet       Date:  1977-10       Impact factor: 6.318

Review 7.  The nosology of the spinal muscular atrophies.

Authors:  A E Emery
Journal:  J Med Genet       Date:  1971-12       Impact factor: 6.318

8.  International collaborative study of the spinal muscular atrophies. Part 2. Analysis of genetic data.

Authors:  A E Emery; A M Davie; S Holloway; R skinner
Journal:  J Neurol Sci       Date:  1976-12       Impact factor: 3.181

9.  Segregation analysis of chronic childhood spinal muscular atrophy.

Authors:  J Pearn
Journal:  J Med Genet       Date:  1978-12       Impact factor: 6.318

10.  Acute Werdnig-Hoffmann disease: acute infantile spinal muscular atrophy.

Authors:  J H Pearn; J Wilson
Journal:  Arch Dis Child       Date:  1973-06       Impact factor: 3.791

View more
  146 in total

1.  Joint effect of the SMN2 and SERF1A genes on childhood-onset types of spinal muscular atrophy in Serbian patients.

Authors:  Miloš Brkušanin; Ana Kosać; Vladimir Jovanović; Jovan Pešović; Goran Brajušković; Nikola Dimitrijević; Slobodanka Todorović; Stanka Romac; Vedrana Milić Rašić; Dušanka Savić-Pavićević
Journal:  J Hum Genet       Date:  2015-08-27       Impact factor: 3.172

2.  Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.

Authors:  Chitra C Iyer; Vicki L McGovern; Jason D Murray; Sara E Gombash; Phillip G Zaworski; Kevin D Foust; Paul M L Janssen; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2015-08-13       Impact factor: 6.150

3.  Population data on acute infantile and chronic childhood spinal muscular atrophy in Warsaw.

Authors:  A W Spiegler; I Hausmanowa-Pertrusewicz; J Borkowska; A Kłopocka
Journal:  Hum Genet       Date:  1990-07       Impact factor: 4.132

4.  Discovery, synthesis, and biological evaluation of novel SMN protein modulators.

Authors:  Jingbo Xiao; Juan J Marugan; Wei Zheng; Steve Titus; Noel Southall; Jonathan J Cherry; Matthew Evans; Elliot J Androphy; Christopher P Austin
Journal:  J Med Chem       Date:  2011-08-19       Impact factor: 7.446

5.  Polar body biopsy in the diagnosis of monogenic diseases: the birth of three healthy children.

Authors:  Georg Griesinger; Nana Bündgen; Diana Salmen; Eberhard Schwinger; Gabriele Gillessen-Kaesbach; Klaus Diedrich
Journal:  Dtsch Arztebl Int       Date:  2009-08-14       Impact factor: 5.594

6.  Spinal muscular atrophy genetic counseling access and genetic knowledge: parents' perspectives.

Authors:  Candice Meldrum; Charles Scott; Kathryn J Swoboda
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

Review 7.  Spinal muscular atrophy.

Authors:  Susan T Iannaccone; Stephen A Smith; Louise R Simard
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

8.  SMN is required for sensory-motor circuit function in Drosophila.

Authors:  Wendy L Imlach; Erin S Beck; Ben Jiwon Choi; Francesco Lotti; Livio Pellizzoni; Brian D McCabe
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582

9.  Plastin 3 is upregulated in iPSC-derived motoneurons from asymptomatic SMN1-deleted individuals.

Authors:  Ludwig Heesen; Michael Peitz; Laura Torres-Benito; Irmgard Hölker; Kristina Hupperich; Kristina Dobrindt; Johannes Jungverdorben; Swetlana Ritzenhofen; Beatrice Weykopf; Daniela Eckert; Seyyed Mohsen Hosseini-Barkooie; Markus Storbeck; Noemi Fusaki; Renata Lonigro; Raoul Heller; Min Jeong Kye; Oliver Brüstle; Brunhilde Wirth
Journal:  Cell Mol Life Sci       Date:  2015-11-16       Impact factor: 9.261

10.  Intragenic complementation of amino and carboxy terminal SMN missense mutations can rescue Smn null mice.

Authors:  Vicki L McGovern; Kaitlyn M Kray; W David Arnold; Sandra I Duque; Chitra C Iyer; Aurélie Massoni-Laporte; Eileen Workman; Aalapi Patel; Daniel J Battle; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2020-11-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.